|
C20ORF43 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.517020E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.911400E-01 |
| Normal-vs-Stage2 |
1.258790E-01 |
| Normal-vs-Stage3 |
2.243600E-02 |
| Normal-vs-Stage4 |
2.931200E-01 |
| Stage1-vs-Stage2 |
1.890800E-01 |
| Stage1-vs-Stage3 |
1.358010E-02 |
| Stage1-vs-Stage4 |
4.979800E-01 |
| Stage2-vs-Stage3 |
6.275800E-01 |
| Stage2-vs-Stage4 |
6.803000E-01 |
| Stage3-vs-Stage4 |
3.117000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.591230E-01 |
| Normal-vs-AfricanAmerican |
3.831800E-01 |
| Normal-vs-Asian |
1.493450E-01 |
| Caucasian-vs-AfricanAmerican |
8.967800E-01 |
| Caucasian-vs-Asian |
3.745600E-01 |
| AfricanAmerican-vs-Asian |
4.139600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.915700E-02 |
| Normal-vs-Female |
6.026600E-01 |
| Male-vs-Female |
7.030000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.218000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.602000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.104780E-01 |
| Normal-vs-Age(81-100Yrs) |
3.429400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.996200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.130600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.104000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.545800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.164800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.847600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.026400E-02 |
| Normal-vs-Grade 2 |
4.623200E-01 |
| Normal-vs-Grade 3 |
1.190650E-01 |
| Normal-vs-Grade 4 |
1.063550E-02 |
| Grade 1-vs-Grade 2 |
1.808440E-02 |
| Grade 1-vs-Grade 3 |
1.186130E-02 |
| Grade 1-vs-Grade 4 |
3.738900E-03 |
| Grade 2-vs-Grade 3 |
1.764360E-01 |
| Grade 2-vs-Grade 4 |
1.481950E-02 |
| Grade 3-vs-Grade 4 |
1.182630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.765000E-01 |
| Normal-vs-ccB subtype |
3.963500E-03 |
| ccA subtype-vs-ccB subtype |
1.55367999999934E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.559420E-01 |
| Normal-vs-N1 |
1.554230E-01 |
| N0-vs-N1 |
4.898800E-01 |
|
|
